Dr. Faz Chowdhurry, CEO of Nemaura Medical

Facebooktwitterlinkedinmail

Dr. Faz Chowdhurry, CEO of Nemaura Medical

RedChip’s exclusive interview with Dr. Faz Chowdhurry, CEO of Nemaura Medical (NASDAQ: NMRD). Nemaura is a medical technology company developing SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) designed to help people with diabetes and pre-diabetics better manage their glucose levels by spending more time in range. Insulin users can adjunctively use SugarBEAT® when calibrated by a finger stick reading. SugarBEAT® consists of a daily, disposable adhesive skin-patch connected to a small form factor rechargeable transmitter, connected via Bluetooth to a specially designed mobile application, which displays glucose readings at five-minute intervals throughout the day.

Facebooktwitterlinkedinmail